140 related articles for article (PubMed ID: 2767522)
41. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
[TBL] [Abstract][Full Text] [Related]
42. Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis.
Corrado F; Ferri C; Mannini D; Corrado G; Bertoni F; Bacchini P; Lelli G; Lieber MM; Song JM
J Urol; 1991 Jun; 145(6):1159-63. PubMed ID: 2033684
[TBL] [Abstract][Full Text] [Related]
43. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
[TBL] [Abstract][Full Text] [Related]
44. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
[TBL] [Abstract][Full Text] [Related]
45. DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma.
Grignon DJ; el-Naggar A; Green LK; Ayala AG; Ro JY; Swanson DA; Troncoso P; McLemore D; Giacco GG; Guinee VF
Cancer; 1989 Mar; 63(6):1161-5. PubMed ID: 2917319
[TBL] [Abstract][Full Text] [Related]
46. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
[TBL] [Abstract][Full Text] [Related]
47. [Nuclear DNA analysis of hepatocellular carcinoma].
Fujimoto J; Okamoto E; Yamanaka N; Fujiwara S; Kato T; Mitsunobu M; Toyosaka A
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1568-70. PubMed ID: 2555666
[TBL] [Abstract][Full Text] [Related]
48. Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway.
Ørbo A; Rydningen M; Straume B; Lysne S
Int J Gynecol Cancer; 2002; 12(1):49-56. PubMed ID: 11913358
[TBL] [Abstract][Full Text] [Related]
49. Flow cytometric DNA ploidy pattern for predicting metastasis of clinical stage I nonseminomatous germ cell testicular tumors.
Austenfeld MS; Bilhartz DL; Nativ O; Farrow GM; Lieber MM
Urology; 1993 Apr; 41(4):379-83. PubMed ID: 8385834
[TBL] [Abstract][Full Text] [Related]
50. Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients.
Podratz KC; Wilson TO; Gaffey TA; Cha SS; Katzmann JA
Am J Obstet Gynecol; 1993 Apr; 168(4):1206-13; discussion 1213-5. PubMed ID: 8475967
[TBL] [Abstract][Full Text] [Related]
51. [Prognostic significance of the DNA ploidy of the early glottic cancer].
Yasuda N; Omori A; Goto T; Hisa Y; Murakami Y; Otsuki T
Nihon Jibiinkoka Gakkai Kaiho; 1990 Aug; 93(8):1171-8. PubMed ID: 2231166
[TBL] [Abstract][Full Text] [Related]
52. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
53. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
[TBL] [Abstract][Full Text] [Related]
54. Transitional cell carcinoma of the renal pelvis and ureter in Taiwan. DNA analysis by flow cytometry.
Chiang PH; Huang MS; Tsai CJ; Tsai EM; Huang CH; Chiang CP
Cancer; 1993 Jun; 71(12):3988-92. PubMed ID: 8508364
[TBL] [Abstract][Full Text] [Related]
55. Effects of DNA ploidy patterns on the survival of patients with primary gastrointestinal lymphoma.
Okuda A; Suzuki H
Surg Today; 1996; 26(8):586-90. PubMed ID: 8855489
[TBL] [Abstract][Full Text] [Related]
56. Uterine leiomyosarcomas and benign smooth muscle tumors: usefulness of nuclear DNA patterns studied by flow cytometry.
Tsushima K; Stanhope CR; Gaffey TA; Lieber MM
Mayo Clin Proc; 1988 Mar; 63(3):248-55. PubMed ID: 3343869
[TBL] [Abstract][Full Text] [Related]
57. [Flow cytometric DNA analysis on renal cell carcinoma--a study of 116 cases on fresh surgical specimens].
Nakazawa H; Ito F; Okuda H; Ryoji O; Kihara T; Goya N; Takahashi K; Toma H
Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):242-50. PubMed ID: 8121106
[TBL] [Abstract][Full Text] [Related]
58. [Flow cytometric DNA analysis in colorectal cancer].
Ando Y; Tsuchiya A; Sekikawa K; Ishii Y; Yoshida T; Kimijima I; Abe R
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1571-5. PubMed ID: 2586468
[TBL] [Abstract][Full Text] [Related]
59. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer.
Pollack A; Zagars GK; el-Naggar AK; Terry NH
Urology; 1994 Nov; 44(5):711-8. PubMed ID: 7526527
[TBL] [Abstract][Full Text] [Related]
60. DNA content as a prognostic factor in endometrial carcinoma.
Newbury R; Schuerch C; Goodspeed N; Fanning J; Glidewell O; Evans M
Obstet Gynecol; 1990 Aug; 76(2):251-7. PubMed ID: 2371030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
